2025-04-10 - Analysis Report
## Salesforce Inc. (CRM) Stock Review

**0. Key Figures:**

* **Cumulative Return (CRM):** 22.78%
* **Cumulative Return (VOO):** 66.94%
* **Return Difference:** -44.2%  (Relative Divergence: 16%)
* **Current Price:** $265.17
* **Market Risk Indicator (MRI):** 0.5289 (High Risk)


**1. Performance Comparison & Company Overview:**

Salesforce Inc. (CRM) is a cloud-based software company providing customer relationship management (CRM) services.  Compared to the S&P 500 (VOO), CRM significantly underperformed, showing a 44.2% lower cumulative return. The relative divergence of 16% indicates that this underperformance sits in the lower part of the historical range of the difference between CRM and VOO.

Alpha and Beta Analysis shows consistently positive alpha values from 2017-2021, indicating outperformance relative to the market. However, the dramatic negative CAGR (-93% in 2020-2022 and -46% in 2021-2023) greatly impacted overall returns.  The high beta values (mostly above 1) suggest high market sensitivity. The significant increase in market capitalization (Cap(B)) demonstrates substantial growth over the years, even with periods of underperformance.


**2. Recent Price Movements:**

* **Closing Price:** $265.17
* **5-day Moving Average:** $249.87
* **20-day Moving Average:** $270.62
* **60-day Moving Average:** $302.83

The current price is below all three moving averages, suggesting a potential downward trend. The recent price increase from the previous close ($243.99 to $265.17) indicates a significant jump (8.68$).  This sharp increase warrants further investigation into the underlying factors.


**3. Technical Indicators & Expected Return:**

* **RSI:** 42.18 (Below 50, suggesting bearish momentum)
* **PPO:** -0.4173 (Negative value indicates bearish momentum)
* **20-Day Relative Divergence Change:** +2.5 (Suggests short-term upward momentum)
* **Market Risk Indicator (MRI):** 0.5289 (High Risk)
* **Expected Return:** -168.4% (This extremely negative figure indicates significant downside risk over the long term compared to the S&P 500.  This requires careful scrutiny, as such a drastic negative return is unlikely to be a realistic projection)


The conflicting signals from the RSI, PPO, and relative divergence suggest a period of uncertainty. The high Market Risk Indicator further supports this concern. The extremely negative expected return necessitates a thorough reassessment of the underlying assumptions and model used to generate this prediction.


**4. Recent Earnings Analysis:**

| Date       | EPS   | Revenue      |
|------------|-------|---------------|
| 2024-12-04 | $1.60 | $9.44 Billion |
| 2024-08-29 | $1.48 | $9.32 Billion |
| 2024-05-30 | $1.58 | $9.13 Billion |
| 2023-11-30 | $1.26 | $8.72 Billion |
| 2024-12-04 | $1.26 | $8.72 Billion | *(Duplicate Entry)*


Earnings show a generally upward trend in both EPS and revenue, though there's some fluctuation. The duplicate entry for 2024-12-04 needs clarification.


**5. Financial Information:**

**Revenue and Profitability:**

| Quarter    | Revenue    | Profit Margin |
|------------|------------|---------------|
| 2025-01-31 | $9.99B     | 77.81%        |
| 2024-10-31 | $9.44B     | 77.71%        |
| 2024-07-31 | $9.32B     | 76.85%        |
| 2024-04-30 | $9.13B     | 76.33%        |
| 2024-01-31 | $9.29B     | 76.87%        |

**Capital and Profitability:**

| Quarter    | Equity      | ROE           |
|------------|-------------|---------------|
| 2025-01-31 | $61.17B     | 2.79%         |
| 2024-10-31 | $58.52B     | 2.61%         |
| 2024-07-31 | $57.63B     | 2.48%         |
| 2024-04-30 | $59.68B     | 2.57%         |
| 2024-01-31 | $59.65B     | 2.42%         |

Both revenue and profit margins show a consistent upward trend.  Equity fluctuates but remains generally high. ROE is relatively stable and low, implying efficient use of equity but not exceptional profitability.


**6. Overall Analysis:**

Salesforce (CRM) has demonstrated significant growth in revenue and profit margins, though recent stock performance significantly underperformed the S&P 500.  The recent price jump needs further analysis to determine its sustainability.  Technical indicators offer conflicting signals, while the exceptionally negative long-term expected return needs careful review and validation.  High market risk and the fluctuating historical performance warrant a cautious approach.  Further investigation into the drivers of the recent price surge and the extremely pessimistic long-term expected return is crucial before making any investment decisions.  The data presented suggests a complex situation requiring more in-depth analysis beyond the scope of this brief review.
